Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00888316 · ClinicalTrials.gov registry record
Iron Overload in Patients Undergoing Donor Stem Cell Transplant
A clinical trial of Cancer and Hematopoietic Stem Cell Transplantation, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- 112
- Enrollment target
- 1
- Study location
NCT00888316 is a study of Cancer and Hematopoietic Stem Cell Transplantation that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 112 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00888316, a study of Cancer and Hematopoietic Stem Cell Transplantation, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Learning about the effect of excess iron in the liver of patients undergoing donor stem cell transplant may help doctors plan treatment. PURPOSE: This study is investigating the effects of iron overload in patients undergoing donor stem cell transplant.
Conditions Studied
Interventions
- PROCEDURE magnetic resonance imaging
- PROCEDURE Serum ferritin
Study Locations (1)
Minnesota
- University of Minnesota Children's Hospital - Fairview - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00888316
The ClinicalTrials.gov registry entry for NCT00888316 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which magnetic resonance imaging is the first listed.
NCT00888316 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00888316 about?
NCT00888316 is a clinical study titled "Iron Overload in Patients Undergoing Donor Stem Cell Transplant". RATIONALE: Learning about the effect of excess iron in the liver of patients undergoing donor stem cell transplant may help doctors plan treatment. PURPOSE: This study is investigating the effects of iron overload in patients undergoing donor stem cell transplant.
What is the current status of trial NCT00888316?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2008-12. Estimated completion is 2012-06.
What conditions does trial NCT00888316 study?
This clinical trial studies the following conditions: Cancer, Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Cell Transplantation.
What interventions are being tested in trial NCT00888316?
The interventions under investigation include: magnetic resonance imaging (PROCEDURE), Serum ferritin (PROCEDURE).
Who is sponsoring clinical trial NCT00888316?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00888316 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.